Display options
Share it on

Front Microbiol. 2016 Jun 28;7:1024. doi: 10.3389/fmicb.2016.01024. eCollection 2016.

Development of a Phage Cocktail to Control Proteus mirabilis Catheter-associated Urinary Tract Infections.

Frontiers in microbiology

Luís D R Melo, Patrícia Veiga, Nuno Cerca, Andrew M Kropinski, Carina Almeida, Joana Azeredo, Sanna Sillankorva

Affiliations

  1. Laboratório de Investigação em Biofilmes Rosário Oliveira, Centre of Biological Engineering, University of Minho Braga Braga, Portugal.
  2. Departments of Food Science, Molecular and Cellular Biology, and Pathobiology, University of Guelph, Guelph ON, Canada.

PMID: 27446059 PMCID: PMC4923195 DOI: 10.3389/fmicb.2016.01024

Abstract

Proteus mirabilis is an enterobacterium that causes catheter-associated urinary tract infections (CAUTIs) due to its ability to colonize and form crystalline biofilms on the catheters surface. CAUTIs are very difficult to treat, since biofilm structures are highly tolerant to antibiotics. Phages have been used widely to control a diversity of bacterial species, however, a limited number of phages for P. mirabilis have been isolated and studied. Here we report the isolation of two novel virulent phages, the podovirus vB_PmiP_5460 and the myovirus vB_PmiM_5461, which are able to target, respectively, 16 of the 26 and all the Proteus strains tested in this study. Both phages have been characterized thoroughly and sequencing data revealed no traces of genes associated with lysogeny. To further evaluate the phages' ability to prevent catheter's colonization by Proteus, the phages adherence to silicone surfaces was assessed. Further tests in phage-coated catheters using a dynamic biofilm model simulating CAUTIs, have shown a significant reduction of P. mirabilis biofilm formation up to 168 h of catheterization. These results highlight the potential usefulness of the two isolated phages for the prevention of surface colonization by this bacterium.

Keywords: Proteus mirabilis; bacteriophage therapy; bacteriophages; biofilms; phage cocktail; urinary tract infection

References

  1. World J Urol. 1999 Dec;17(6):345-50 - PubMed
  2. Microbiology. 1997 Jan;143 ( Pt 1):179-85 - PubMed
  3. Nat Rev Urol. 2012 Apr 17;9(6):305-14 - PubMed
  4. Methods Mol Biol. 2009;501:69-76 - PubMed
  5. J Antimicrob Chemother. 2014 Sep;69(9):2326-36 - PubMed
  6. Nature. 2014 Jun 5;510(7503):15-6 - PubMed
  7. BMC Bioinformatics. 2002 Apr 24;3:12 - PubMed
  8. J Gen Virol. 2014 Feb;95(Pt 2):506-15 - PubMed
  9. Genome Res. 2007 Oct;17(10):1486-95 - PubMed
  10. Clin Infect Dis. 2008 Jan 15;46(2):243-50 - PubMed
  11. Eur J Biochem. 2000 Apr;267(8):2439-46 - PubMed
  12. Biofouling. 2011 Nov;27(10):1087-93 - PubMed
  13. Methods Mol Biol. 2009;501:113-26 - PubMed
  14. FEBS Lett. 2002 Dec 18;532(3):415-8 - PubMed
  15. PLoS One. 2012;7(3):e31698 - PubMed
  16. Spinal Cord. 2010 Nov;48(11):784-90 - PubMed
  17. Curr Pharm Biotechnol. 2008 Aug;9(4):261-6 - PubMed
  18. Methods Mol Biol. 1999;112:531-52 - PubMed
  19. Trends Genet. 2002 Jun;18(6):291-4 - PubMed
  20. Bioinformatics. 2004 Mar 22;20(5):629-35 - PubMed
  21. J Mol Biol. 2004 May 14;338(5):1027-36 - PubMed
  22. FEMS Immunol Med Microbiol. 2010 Aug;59(3):447-55 - PubMed
  23. J Appl Microbiol. 2006 May;100(5):1028-33 - PubMed
  24. J Med Microbiol. 2010 Jul;59(Pt 7):747-54 - PubMed
  25. Infect Control Hosp Epidemiol. 2011 Aug;32(8):822-3 - PubMed
  26. Biochemistry (Mosc). 2011 Jul;76(7):851-61 - PubMed
  27. Microbes Infect. 2000 Oct;2(12):1497-505 - PubMed
  28. Nucleic Acids Res. 2004 Jan 02;32(1):11-6 - PubMed
  29. Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W465-9 - PubMed
  30. J Med Microbiol. 2014 Nov;63(Pt 11):1561-7 - PubMed
  31. Nat Rev Microbiol. 2013 Oct;11(10):675-87 - PubMed
  32. Clin Microbiol Rev. 2008 Jan;21(1):26-59 - PubMed
  33. Nucleic Acids Res. 2009 Jul;37(Web Server issue):W202-8 - PubMed
  34. Arch Intern Med. 1999 Apr 26;159(8):800-8 - PubMed
  35. Trends Genet. 2000 Jun;16(6):276-7 - PubMed
  36. Lett Appl Microbiol. 1997 Mar;24(3):203-6 - PubMed
  37. BMC Genomics. 2008 Feb 08;9:75 - PubMed
  38. Nucleic Acids Res. 2014 Jan;42(Database issue):D222-30 - PubMed
  39. Pol J Microbiol. 2013;62(4):377-84 - PubMed
  40. Age Ageing. 2006 Sep;35(5):477-81 - PubMed
  41. RNA Biol. 2011 Jan-Feb;8(1):11-3 - PubMed
  42. J Mol Biol. 1990 Oct 5;215(3):403-10 - PubMed
  43. Antimicrob Agents Chemother. 2015 Feb;59(2):1127-37 - PubMed
  44. Infect Control Hosp Epidemiol. 2011 Aug;32(8):748-56 - PubMed
  45. J Med Microbiol. 2006 May;55(Pt 5):489-94 - PubMed
  46. Res Microbiol. 2011 Oct;162(8):798-806 - PubMed
  47. Nat Rev Microbiol. 2012 Nov;10(11):743-54 - PubMed
  48. Eur J Clin Microbiol Infect Dis. 1998 Sep;17(9):649-52 - PubMed
  49. BMC Infect Dis. 2014 Sep 05;14:486 - PubMed
  50. J Microbiol Methods. 2000 Apr;40(2):175-9 - PubMed
  51. Biomaterials. 2010 Mar;31(7):1904-10 - PubMed
  52. Folia Microbiol (Praha). 2011 May;56(3):191-200 - PubMed
  53. Infect Dis Clin North Am. 2014 Mar;28(1):105-19 - PubMed
  54. Res Microbiol. 2014 Oct;165(8):679-85 - PubMed
  55. Clin Microbiol Rev. 2000 Oct;13(4):534-46 - PubMed
  56. Adv Healthc Mater. 2014 Oct;3(10):1588-96 - PubMed
  57. J Med Microbiol. 2009 Oct;58(Pt 10):1367-75 - PubMed
  58. J Ind Microbiol. 1996 Jun;16(6):331-41 - PubMed
  59. Nucleic Acids Res. 1997 Sep 1;25(17):3389-402 - PubMed
  60. Nucleic Acids Res. 2003 Jul 1;31(13):3406-15 - PubMed
  61. Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W686-9 - PubMed
  62. Langmuir. 2011 May 3;27(9):5472-80 - PubMed
  63. J Med Microbiol. 2005 Sep;54(Pt 9):807-13 - PubMed

Publication Types